Study guide

Oncologic Emergency TLS SVC Cord Compression Case Lab

OCN Oncology Certified Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: OCN Exam Orientation and Official Source Control

Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness

2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care

Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures

3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment

Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation

4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards

Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development

5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy

Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation

6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents

Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation

7 Chapter 7: Symptom Management and Supportive Care

Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination

8 Chapter 8: Oncologic Emergencies and Rapid Escalation

Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage

9 Chapter 9: Psychosocial Dimensions of Oncology Care

Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals

10 Chapter 10: Mixed OCN Case Labs

New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab

11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness

Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning

Oncologic Emergency TLS SVC Cord Compression Case Lab

Key Takeaways Explain This Topic AI

Tumor lysis syndrome causes hyperkalemia, hyperphosphatemia, hyperuricemia, and HYPOcalcemia; aggressive IV hydration plus allopurinol (prevention) or rasburicase (high risk/established) protect the kidneys.

Never give rasburicase to a patient with G6PD deficiency; it causes severe hemolysis and methemoglobinemia.

Superior vena cava syndrome priority is airway/breathing: elevate the head of bed, assess respiratory status, and escalate; do NOT lay the patient flat.

Malignant spinal cord compression is a true emergency; with neurologic deficits, IV corticosteroids (dexamethasone) are started urgently while imaging (MRI) and radiation/surgery are arranged.

Do not delay escalation for complete diagnostic confirmation when red flags are present; pain often precedes neurologic deficit in cord compression.

Last updated: October 2026

  • Case Lab: TLS, SVC Syndrome, and Spinal Cord Compression
  • Case Snapshot

A patient with newly diagnosed high-grade lymphoma starts treatment and develops nausea, muscle cramps, weakness, and decreasing urine output. A second patient with lung cancer reports facial swelling, dyspnea when supine, and visible distended chest veins. A third with metastatic prostate cancer calls with new severe back pain, leg weakness, and urinary retention. These represent tumor lysis syndrome (TLS) , superior vena cava (SVC) syndrome , and malignant spinal cord compression - three high-priority oncologic emergencies the OCN exam tests repeatedly as first-action questions.

Tumor Lysis Syndrome

TLS occurs when rapid tumor-cell breakdown dumps intracellular contents into the blood: hyperkalemia, hyperphosphatemia, hyperuricemia, and secondary HYPOcalcemia (phosphate binds calcium). The result can be acute kidney injury, dysrhythmias, tetany, seizures, and death. Risk is highest with bulky, rapidly proliferating, chemo-sensitive disease, such as Burkitt lymphoma, acute leukemias, and other high-grade lymphomas, and usually appears 12-72 hours after therapy starts, though it can occur spontaneously.

Emergency Clues Why It Matters RN Priority

TLS Cramps, weakness, nausea, oliguria; high K+, phosphate, uric acid; low calcium; rising creatinine Renal failure, dysrhythmia, seizure Aggressive IV hydration, telemetry/ECG, labs, allopurinol or rasburicase per order, escalate

SVC syndrome Face/neck swelling, dyspnea, cough, distended veins, worse supine Airway and cerebral edema Elevate HOB, assess airway/breathing, urgent provider contact

Cord compression New back pain, weakness, sensory level, bowel/bladder change Permanent paralysis MRI, neuro assessment, urgent IV dexamethasone per order

TLS prevention and care include risk recognition before treatment, aggressive IV hydration , strict intake/output and daily weights, telemetry, and lab surveillance of potassium, phosphate, calcium, uric acid, and creatinine. Allopurinol prevents new uric acid formation (prophylaxis); rasburicase breaks down existing uric acid for high-risk or established TLS. A critical safety rule: never give rasburicase to a patient with G6PD deficiency because it triggers severe hemolysis and methemoglobinemia. Escalate before instability develops; do not wait for the patient to crash.

Superior Vena Cava Syndrome

SVC syndrome is obstruction of venous return from the head, neck, arms, and chest, from tumor compression (often lung cancer or lymphoma), thrombosis, or catheter complication. Findings include facial or arm swelling, head fullness, dyspnea, cough, hoarseness, stridor, headache, confusion, distended neck/chest veins, and symptoms worse when bending or lying flat. Airway and breathing are the priority: elevate the head of the bed , assess respiratory status, SpO2, and neuro status, then escalate urgently. Never lay the patient flat. Severe stridor, confusion, syncope, or distress requires emergency response.

Definitive treatment (radiation, chemotherapy, steroids, anticoagulation, or stenting) is provider-directed; the RN role is rapid recognition, positioning, supportive care, and escalation.

Malignant Spinal Cord Compression

Malignant spinal cord compression can cause permanent neurologic loss within hours. Red flags: new localized back pain, pain worse when lying down or with Valsalva, radicular pain, weakness, gait change, a sensory level, numbness, and bowel or bladder dysfunction. Pain commonly precedes neurologic deficit , so waiting for paralysis is unsafe. The prostate-cancer patient with back pain, leg weakness, and urinary retention needs emergency evaluation: assess neuro function, pain, mobility, bowel/bladder status, and fall risk, then escalate immediately.

Protect safety, avoid unnecessary ambulation if weakness is present, and prepare for urgent MRI and IV dexamethasone , followed by radiation or surgical decompression. Do not offer massage or routine outpatient analgesic changes as the only action.

Education, Documentation, and Reassessment

Teach at-risk patients clear triggers: fever after chemotherapy, decreased urine, palpitations, severe weakness or cramps, facial swelling, breathing trouble, new neurologic deficits, and back pain with weakness or bowel/bladder change. Documentation includes symptom onset, diagnosis and treatment timing, objective assessment, vitals, neuro findings, urine output, labs, provider notification, orders, response, and transfer details. Reassessment focuses on airway, hemodynamics, neuro status, urine output, electrolytes, and response to interventions.

On OCN first-action questions, choose the answer that prevents irreversible harm : protect the airway in SVC syndrome, protect the kidneys in TLS, and protect neurologic function in cord compression.

Numbers, Look-Alikes, and Common Traps

The Cairo-Bishop definition codifies laboratory TLS as two or more abnormalities within three days before to seven days after treatment: uric acid >=8 mg/dL, potassium >=6 mEq/L, phosphorus elevated, and calcium <=7 mg/dL (or a 25% change from baseline). Clinical TLS adds AKI, cardiac dysrhythmia, or seizure. Hyperkalemia is the most immediately life-threatening abnormality because it triggers peaked T waves and fatal dysrhythmias, so continuous telemetry and a stat potassium are priorities. The phosphate-calcium relationship is inverse, which is why TLS produces hypocalcemia, not hypercalcemia.

Facts that separate the right answer from the look-alike:

Hypercalcemia of malignancy is a different emergency (confusion, constipation, polyuria, weakness) treated with IV fluids and bisphosphonates; do not confuse its high calcium with TLS's low calcium.

SVC syndrome positioning is upright with head elevated ; lying flat is always wrong.

Cord-compression imaging of choice is MRI of the whole spine , and dexamethasone is started urgently to reduce cord edema while definitive radiation or surgery is arranged.

The phrase "do not delay escalation for confirmation" is the recurring theme: red flags drive action before labs or imaging return.

The most common distractors offer comfort measures, routine follow-up, or waiting for test results when red flags are already present. For each emergency, pick the action that prevents irreversible organ loss within the next hour, not the one that is merely reassuring.